http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019517471-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 2017-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019517471-A |
| titleOfInvention | Compositions and methods using MIR-302 precursor as an anti-cancer drug to treat human lung cancer |
| abstract | The present invention relates generally to compositions and methods using artificial small RNAs, such as small interfering RNAs (siRNAs), microRNAs (miRNAs) and their hairpin precursors (pre-miRNAs) as tumor suppressor anticancer agents. And cancer, in particular all three tissues including skin cancer (melanoma), blood cancer (leukemia), prostate cancer, breast cancer, liver cancer and lung cancer, and various neoplastic tumors such as ectoderm, mesoderm and endoderm. It can be used in the treatment of brain tumors and teratomas, including but not limited to various tumor cells and cancer cells derived from two germ layers. More specifically, the present invention relates to miR-302s siRNA (siR-302) and / or miR-302 precursor (pre-) for developing novel drugs and therapies for a wide variety of human cancers, in particular lung cancer. The use of miR-302). |
| priorityDate | 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 977.